Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Cell Genesys

Founders Larry Green Raju Kucherlapati Robert Tepper

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$28M
Portfolio companies 1
Rounds per year 0.03
Lead investments 0
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Diagnostics
  • Pharmaceutical
Summary

In 1988 was created Cell Genesys, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Hayward. The company was established in North America in United States.

The fund is generally included in less than 2 deals every year. The important activity for fund was in 2007. The top amount of exits for fund were in 2013. The common things for fund are deals in the range of 10 - 50 millions dollars.

The standard case for the fund is to invest in rounds with 6 partakers. Despite the Cell Genesys, startups are often financed by MPM Capital, HamiltonApex Technology Ventures, California Technology Ventures. The meaningful sponsors for the fund in investment in the same round are MPM Capital, Investor Growth Capital Limited, Hamilton BioVentures. In the next rounds fund is usually obtained by Michael J. Fox Foundation.

This organization was formed by Larry Green, Raju Kucherlapati, Robert Tepper.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Diagnostics, Biotechnology. Among the various public portfolio startups of the fund, we may underline Ceregene

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Cell Genesys:
Typical Co-investors
Cell Genesys is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Cell Genesys:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
ANAP Japan, Minato
Boston Celtics Boston, Massachusetts, United States
Centricus England, London, United Kingdom
Changzhou Properties Changzhou, China, Zhejiang
CLP Group -
El Al Israeli Airlines Israel, Tel Aviv, Tel Aviv District
Epublica Germany, Hamburg
hatchbrands Canada, Ontario, Ottawa
Healthcare Equity Partners Chicago, Illinois, United States
Honeywell Aerospace Arizona, Phoenix, United States
JMB Capital Partners California, Los Angeles, United States
Keller Capital Austin, Texas, United States
Michael Altrichter Beteiligungs GmbH Allhartsberg, Austria, Niederosterreich
Michigan Accelerator Fund I Grand Rapids, Michigan, United States
SunAmerica Ventures California, Los Angeles, United States
Sustainable Conversion Ventures -
Tianji Touzi China, Shanghai
Vallis Capital Partners Brazil, Rio Grande do Sul, Viamão
YLZ Information Technology China, Fujian, Xiamen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Ceregene

Biotechnology
Health Diagnostics
Pharmaceutical
$28M22 Jun 2007 San Diego, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Cell Genesys?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 28M
Rounds per year 0.03
Peak activity year 2007
Lead investments 0
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Ceregene

Biotechnology
Health Diagnostics
Pharmaceutical
$28M22 Jun 2007 San Diego, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: